Clinical Research Directory

Inclusion criteria : * Age greater than or equal to 18 years ; * Frequent episodic or chronic migraine: migraine more than 8 days per month for more than 3 months; * Maximum 26 headache days / 28 ; * Failure (ineffectiveness, intolerance or contraindication) to at least 3 background drug treatments; * Analgesic treatment stable for at least one month and will not need to be modified for the duration of the study; * Patient can be followed throughout the study; * Information letter read and understood; * Signed informed consent; * Affiliation with a social security scheme. Exclusion Criteria: * Contraindication to rTMS (patient with conductive/sensitive material to magnetic fields implanted in the skull or less than 30 cm from the coil, implanted material controlled by physiological signals, history of epilepsy or unexplained seizures, drug treatment lowering the epileptic threshold, brain lesions in relation to the stimulation zone \[of vascular, traumatic, tumoral, infectious or metabolic origin\], sleep deprivation, alcoholism, treatment with electroconvulsive therapy in the previous month, uncontrolled intracranial hypertension, * Contraindication to MRI (ferromagnetic material not compatible with MRI including: intracerebral metal clip, pacemaker, insulin pump, intrathecal pump, metal prosthesis; severe claustrophobia)§ drug or psychoactive substance abuse * Presence of other pain more severe than that justifying inclusion * Patients under guardianship or deprived of liberty. * Pregnant or breast-feeding women * Patients participating in another research protocol involving a drug in the 30 days prior to inclusion. * Subject having already benefited from rTMS sessions in the past (to maintain the blind)